Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.80% Nasdaq Up0.97%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS

7.98 Down 0.02(0.25%) 4:00PM EDT|After Hours : 7.99 Up 0.01 (0.13%) 6:50PM EDT - Nasdaq Real Time Price

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 27,587   12,719   16,613  
Cost of Revenue3,671  8,100  7,414  
Gross Profit 23,916   4,619   9,199  
Operating Expenses
Research Development54,112  58,706  75,459  
Selling General and Administrative26,226  24,248  27,936  
Non Recurring -  3,467   -  
Others691  997  2,159  
Total Operating Expenses -  87,418   -  
Operating Income or Loss (57,113) (82,799) (96,355)
Income from Continuing Operations
Total Other Income/Expenses Net(19,244)(12,116)(6,498)
Earnings Before Interest And Taxes(76,357)(94,915)(102,853)
Interest Expense9,120  14,309  21,681  
Income Before Tax(85,477)(109,224)(124,534)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(91,815)(119,738)(136,888)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (85,477) (109,224) (124,534)
Preferred Stock And Other Adjustments(2,824)(2,260) -  
Net Income Applicable To Common Shares (88,301) (111,484) (124,534)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.